Novartis | NVS - Current Assets

Stock Price
153.95
Daily Change
-1.22 -0.79%
Monthly
-6.25%
Yearly
37.05%
Q2 Forecast
150.15

Novartis reported $30.46B in Current Assets for its fiscal quarter ending in December of 2025.





Current Assets Change Date
AbbVie USD 29.06B 523M Dec/2025
Amgen USD 29.06B 1.17B Dec/2025
AstraZeneca USD 28.72B 1.22B Dec/2025
Bausch Health Companies USD 6.16B 92M Dec/2025
Biogen USD 8.97B 37.5M Dec/2025
Bristol-Myers Squibb USD 35.63B 2.41B Sep/2025
Canopy Growth CAD 524.67M 78.85M Dec/2025
Corcept Therapeutics USD 485.46M 55.67M Dec/2025
Drreddys Laboratories INR 3.31B 164.26M Dec/2025
Eli Lilly USD 55.63B 6.44B Dec/2025
Gilead Sciences USD 19.89B 1.05B Dec/2025
GlaxoSmithKline GBP 17.51B 332M Dec/2025
Glaxosmithkline GBP 23.59B 390.44M Dec/2025
J&J USD 55.62B 1.01B Dec/2025
Merck USD 47.56B 10.49B Sep/2025
Novartis USD 30.46B 2.26B Dec/2025
Novartis USD 30.46B 2.26B Dec/2025
Pacira USD 547.97M 14.78M Dec/2025
Perrigo USD 2.8B 81.8M Dec/2025
Pfizer USD 46.92B 3.22B Sep/2025
Phibro Animal Health USD 862.18M 26.39M Dec/2025
Prestige Brands USD 433.43M 63.98M Dec/2025
Roche Holding CHF 38.73B 3.03B Dec/2025
Sanofi EUR 30.95B 3.09B Dec/2025
Sanofi EUR 30.95B 8.99B Dec/2025
Supernus Pharmaceuticals USD 644.18M 50.29M Dec/2025
Zoetis USD 6.77B 185M Dec/2025